← Back to Home
DOJOLVI® (triheptanoin) for LC-FAOD
DOJOLVI® (triheptanoin) is the first and only FDA-approved treatment for patients diagnosed with long-chain fatty acid oxidation disorders (LC-FAOD)
Keywords
Color Palette
Primary
#282e3c
Accent
#f59e0b
Background
#ffffff
Secondary 1
#007bff
Secondary 2
#00d0bc
Contact Information
Phone:
+1-800-555-1234
Social Media: